• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Henry Schein, National Dental Association and Schattner Foundation Present Student Mentoring Program for Aspiring Dental Professionals

    2/21/24 6:30:00 AM ET
    $HSIC
    Medical Specialities
    Health Care
    Get the next $HSIC alert in real time by email

    Applications for the Second Annual 2024 S.M.I.L.E. Healthcare Pathway Program are now being accepted

    Henry Schein, Inc. (NASDAQ:HSIC), National Dental Association (NDA), and Schattner Foundation are pleased to partner and present the S.M.I.L.E. (Student Mentoring with Immersive Learning and Enrichment) Healthcare Pathway Program. This innovative public-private partnership is designed to mentor and support aspiring healthcare professionals and enhance inclusivity within the dental field.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240220083937/en/

    Applications are now being accepted for the 2024 program taking place July 7 to 11, 2024, at Meharry Medical College School of Dentistry, Nashville, TN. Joining Henry Schein, the NDA, and Schattner Foundation in presenting the 2024 program are the Hispanic Dental Association, the Society of American Indian Dentists, Meharry Medical College School of Dentistry, and the A.T. Still University's Arizona School of Dentistry & Oral Health, and the A.T. Still University's Missouri School of Dentistry and Oral Health.

    The S.M.I.L.E. Program empowers underrepresented high school students (grades 9-10) with a passion for oral health to gain exposure to the variety of career opportunities available within the oral health profession, including assisting, hygiene, and dentistry, as well as various practice models and industry roles. Through an immersive, week-long experience, the program provides:

    • Mentorship from experienced dental professionals;
    • Hands-on learning of real-world procedures and develop practical skills;
    • Career pathway exposure to discover diverse dental career options; and
    • Capstone project culminating in a presentation focused on translating their learnings into tangible action.

    This comprehensive approach fosters informed career choices, builds essential skills, and empowers future leaders in oral health.

    "We are thrilled to join with our partners to present the S.M.I.L.E. Healthcare Pathway Program," said Dr. Carol Summerhays, Henry Schein S.M.I.L.E. Program Director. "This program represents a significant milestone in our unwavering commitment to promoting diversity and inclusion within the dental profession. Through early exposure, mentorship, and direction, we firmly believe that by introducing students to the dynamic world of dentistry, we can ignite their passion and empower them to pursue careers as dentists, dental hygienists, dental assistants, and dental office administrators. In America, over 30% of the population identify as Black or African American or Hispanic, with that number dropping significantly to less than 10% for dentists.1 We hope to cultivate the next generation of dental professionals to better serve our diverse patient community and strengthen the foundation of our critical health care community."

    In 2023, the inaugural S.M.I.L.E. program took place at three locations: Howard University College of Dentistry, University of Maryland School of Dentistry, and Mary's Center, a federally qualified health center located in the DC Metro area that delivers affordable, accessible, quality, and value-based primary health care. The program was made possible by a generous grant from the Schattner Foundation and the support of other professional organizations.

    The program brought together 34 ninth and tenth-grade students from the Metropolitan DC area, Las Vegas, New York, and Ohio, for an immersive learning experience with dental professionals and specialists. To learn more and gain insights from participants' watch this video.

    "The NDA remains mission-focused and committed to supporting educational initiatives and programs that empower aspiring health care professionals. By partnering with Henry Schein, the Schattner Foundation, and esteemed institutions like Howard University, the University of Maryland, and now Meharry Medical College, we will continue to ‘build bridges' and to make a significant impact in nurturing talent and fostering growth in the dental industry. Together, our collective efforts will help mentor future health care professionals, enhance health literacy, expand diversity in the health care workforce, and ultimately improve health equity and overall outcomes in underserved communities nationwide," said Dr. Marlon Henderson, 99th President of the National Dental Association.

    Applications for the 2024 program at Meharry Medical College School of Dentistry are now being accepted. The application deadline is March 31, 2024. Eligible students can apply by completing the online application form on the official S.M.I.L.E. Program website, https://ndaonline.org/smile-program.

    About Henry Schein, Inc.

    Henry Schein, Inc. (NASDAQ:HSIC) is a solutions company for health care professionals powered by a network of people and technology. With approximately 24,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.

    Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein private-brand products in stock.

    A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 33 countries and territories. The Company's sales reached $12.6 billion in 2022, and have grown at a compound annual rate of approximately 12.1 percent since Henry Schein became a public company in 1995.

    For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein, Instagram.com/HenrySchein, and Twitter.com/HenrySchein.

    About the NDA

    The National Dental Association promotes oral health equity among people of color by harnessing the collective power of its members, advocating for the needs of and mentoring dental students of color, and raising the profile of the profession in our communities. For more information about the NDA, visit www.ndaonline.org.

    About Schattner Foundation

    The Schattner Foundation was established in 1992 by Dr. Robert I. Schattner. Dr. Schattner, the inventor of Chloraseptic and Sporicidin, used his success with these products to make grants where they will do the most good and make a difference. For more information, visit www.robertischattnerfoundation.org.

    1 "U.S. Dentist Demographic Dashboard," American Dental Association, Health Policy Institute

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240220083937/en/

    Get the next $HSIC alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $HSIC

    DatePrice TargetRatingAnalyst
    2/14/2025$80.00Equal Weight
    Wells Fargo
    1/6/2025$69.00 → $84.00Underperform → Buy
    BofA Securities
    12/4/2024$75.00Neutral
    Mizuho
    7/22/2024$81.00 → $92.00Neutral → Outperform
    Robert W. Baird
    2/26/2024$78.00Market Perform
    Leerink Partners
    12/12/2023$71.00 → $82.00Neutral → Overweight
    JP Morgan
    11/10/2023$70.00Hold → Buy
    Stifel
    8/8/2022$80.00Sell → Neutral
    UBS
    More analyst ratings

    $HSIC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Large owner Kkr Hawaii Aggregator L.P.

      4 - HENRY SCHEIN INC (0001000228) (Issuer)

      6/18/25 7:24:32 PM ET
      $HSIC
      Medical Specialities
      Health Care
    • Chairman, CEO Bergman Stanley M gifted 145 units of Common Stock par value $0.01 per shre, decreasing direct ownership by 0.04% to 323,747 units (SEC Form 4)

      4 - HENRY SCHEIN INC (0001000228) (Issuer)

      6/17/25 4:36:56 PM ET
      $HSIC
      Medical Specialities
      Health Care
    • Director Daniel William K was granted 2,849 shares (SEC Form 4)

      4 - HENRY SCHEIN INC (0001000228) (Issuer)

      6/16/25 5:36:46 PM ET
      $HSIC
      Medical Specialities
      Health Care

    $HSIC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Updated: Henry Schein to Participate in Upcoming Investor Conference in June

      Henry Schein, Inc., the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conference in June: Jefferies Global Healthcare Conference at the Marriott Marquis hotel, New York City, on June 4, at 12:50 p.m. Eastern time. Henry Schein's presentations can be heard via live webcast by visiting www.henryschein.com/IRwebcasts. Replays will be available on the Henry Schein website following the presentations. About Henry Schein, Inc. Henry Schein, Inc. (NASDAQ:HSIC) is a solutions company for health care professionals powered by a network of people and technology. With ap

      6/2/25 6:45:00 PM ET
      $HSIC
      Medical Specialities
      Health Care
    • Henry Schein One Unveils The Catalyst Index, a Look into Dentistry's Top 10%

      Patient experience is the differentiator – The Catalyst Index reveals how top practices reduce friction to retain and engage patients Henry Schein One today announced the launch of The 2025 Catalyst Index, its exclusive report offering dental practices an unparalleled view into the strategies transforming performance across the industry. Built on years of trusted benchmarking and informed by Henry Schein One's most connected platform, the fourth annual report, The Catalyst Index, raises the bar by revealing the specific actions that distinguish the top 10% of DSOs and private practices. "We're at a turning point in dentistry," said Dr. Ryan Hungate, Chief Clinical and Strategy Officer, He

      5/20/25 6:30:00 AM ET
      $HSIC
      Medical Specialities
      Health Care
    • Henry Schein Announces Completion of Strategic Investment by KKR and Appointment of Dan Daniel to Board of Directors

      Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced the successful completion of a $250 million strategic investment by funds affiliated with KKR, a leading global investment firm. Upon the closing of this transaction, KKR has become the holder of approximately 12% of the common shares of Henry Schein. In connection with the investment, William K. "Dan" Daniel, Executive Advisor to KKR and former Executive Vice President of Danaher Corporation, has officially joined Henry Schein's Board of Directors as an independent director. He joins Max Lin, Partner at KKR and leader of the firm's Healt

      5/16/25 4:10:00 PM ET
      $HSIC
      $KKR
      Medical Specialities
      Health Care
      Investment Managers
      Finance

    $HSIC
    SEC Filings

    See more
    • SEC Form 11-K filed by Henry Schein Inc.

      11-K - HENRY SCHEIN INC (0001000228) (Filer)

      6/20/25 8:01:34 AM ET
      $HSIC
      Medical Specialities
      Health Care
    • Henry Schein Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement

      8-K - HENRY SCHEIN INC (0001000228) (Filer)

      6/9/25 8:30:38 AM ET
      $HSIC
      Medical Specialities
      Health Care
    • SEC Form SD filed by Henry Schein Inc.

      SD - HENRY SCHEIN INC (0001000228) (Filer)

      5/30/25 4:18:14 PM ET
      $HSIC
      Medical Specialities
      Health Care

    $HSIC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Wells Fargo initiated coverage on Henry Schein with a new price target

      Wells Fargo initiated coverage of Henry Schein with a rating of Equal Weight and set a new price target of $80.00

      2/14/25 7:05:26 AM ET
      $HSIC
      Medical Specialities
      Health Care
    • Henry Schein upgraded by BofA Securities with a new price target

      BofA Securities upgraded Henry Schein from Underperform to Buy and set a new price target of $84.00 from $69.00 previously

      1/6/25 8:12:21 AM ET
      $HSIC
      Medical Specialities
      Health Care
    • Mizuho initiated coverage on Henry Schein with a new price target

      Mizuho initiated coverage of Henry Schein with a rating of Neutral and set a new price target of $75.00

      12/4/24 7:41:29 AM ET
      $HSIC
      Medical Specialities
      Health Care

    $HSIC
    Leadership Updates

    Live Leadership Updates

    See more
    • Henry Schein Announces Completion of Strategic Investment by KKR and Appointment of Dan Daniel to Board of Directors

      Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced the successful completion of a $250 million strategic investment by funds affiliated with KKR, a leading global investment firm. Upon the closing of this transaction, KKR has become the holder of approximately 12% of the common shares of Henry Schein. In connection with the investment, William K. "Dan" Daniel, Executive Advisor to KKR and former Executive Vice President of Danaher Corporation, has officially joined Henry Schein's Board of Directors as an independent director. He joins Max Lin, Partner at KKR and leader of the firm's Healt

      5/16/25 4:10:00 PM ET
      $HSIC
      $KKR
      Medical Specialities
      Health Care
      Investment Managers
      Finance
    • PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair

      Former Baxter and Baxalta Chief Financial Officer brings more than 30 years of biotech financial and operational experience PureTech Health plc (NASDAQ:PRTC, LSE: PRTC)) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company, noted that its Founded Entity, Seaport Therapeutics, ("Seaport") a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team, today announced that Robert "Bob" J. Hombach has been appointed to its Board of Directors and will serve as the Chair of the Audit Committee. Mr. Hombach is a seasoned financial and operational executive with three decades of high-level leadership in the healthca

      3/11/25 7:05:00 AM ET
      $BAX
      $BMRN
      $EMBC
      $HSIC
      Medical/Dental Instruments
      Health Care
      Biotechnology: Pharmaceutical Preparations
      Medical Specialities
    • Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair

      Former Baxter and Baxalta Chief Financial Officer brings more than 30 years of biotech financial and operational experience Seaport Therapeutics ("Seaport" or the "Company"), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team, today announced that Robert "Bob" J. Hombach has been appointed to its Board of Directors and will serve as the Chair of the Audit Committee. Mr. Hombach is a seasoned financial and operational executive with three decades of high-level leadership in the healthcare sector. His experience includes serving on the Audit, Finance and Compensation Committees for several public and private Boards of

      3/11/25 7:00:00 AM ET
      $BAX
      $BMRN
      $EMBC
      $HSIC
      Medical/Dental Instruments
      Health Care
      Biotechnology: Pharmaceutical Preparations
      Medical Specialities

    $HSIC
    Financials

    Live finance-specific insights

    See more
    • Henry Schein Reports First Quarter 2025 Financial Results

      First-quarter 2025 GAAP diluted EPS of $0.88, growth of 22% compared to the first quarter of 2024 First-quarter 2025 non-GAAP diluted EPS of $1.15, growth of 4.5% compared to the first quarter of 2024 Maintains guidance for 2025 non-GAAP diluted EPS of $4.80 to $4.94, mid-single digit 2025 Adjusted EBITDA growth, and sales growth of 2% to 4% Repurchased $161 million of common stock, or approximately 2.3 million shares Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today reported financial results for the first quarter ended March 29, 2025. "We are pleased with our first quarter financial re

      5/5/25 6:00:00 AM ET
      $HSIC
      Medical Specialities
      Health Care
    • Henry Schein to Webcast First Quarter 2025 Conference Call on Monday, May 5th, 2025, at 8:00 a.m. ET

      Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that it will release its first quarter 2025 financial results before the stock market opens on Monday, May 5th, 2025, and will provide a live webcast of its earnings conference call on the same day beginning at 8:00 a.m. Eastern time. Speakers on the call will include Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein, and Ronald N. South, Senior Vice President and Chief Financial Officer. Investors can access the call by visiting https://investor.henryschein.com/webcasts. A replay will be available on

      4/8/25 6:30:00 AM ET
      $HSIC
      Medical Specialities
      Health Care
    • Henry Schein Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Detailed 2025 Financial Guidance

      Fourth-quarter 2024 GAAP diluted EPS of $0.74 and non-GAAP diluted EPS of $1.19 Fourth-quarter 2024 operating cash flow of $204 million; full-year 2024 operating cash flow of $848 million, up $348 million compared with 2023 2025 non-GAAP diluted EPS expected to be in the range of $4.80 to $4.94 with mid-single digit 2025 Adjusted EBITDA growth Announces new reportable segments to provide more meaningful information for investors Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today reported financial results for the fourth quarter and full year ended December 28, 2024. The financial result

      2/25/25 6:00:00 AM ET
      $HSIC
      Medical Specialities
      Health Care

    $HSIC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Henry Schein Inc.

      SC 13G/A - HENRY SCHEIN INC (0001000228) (Subject)

      11/13/24 3:30:01 PM ET
      $HSIC
      Medical Specialities
      Health Care
    • SEC Form SC 13G filed by Henry Schein Inc.

      SC 13G - HENRY SCHEIN INC (0001000228) (Subject)

      11/12/24 9:32:27 AM ET
      $HSIC
      Medical Specialities
      Health Care
    • SEC Form SC 13G/A filed by Henry Schein Inc. (Amendment)

      SC 13G/A - HENRY SCHEIN INC (0001000228) (Subject)

      2/14/24 11:18:57 AM ET
      $HSIC
      Medical Specialities
      Health Care